XNYS · LABORATORY ANALYTICAL INSTRUMENTS · LABORATORY ANALYTICAL INSTRUMENTS
Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.
TL;DR: Avantor posted Q1 2026 net sales of $1.58 billion with net income of $43.3 million, down from $64.5 million in the same quarter last year. The headline number masks a currency story: flat reported revenue actually…
| Institution | Shares | Value ($) | Change % | Filing date |
|---|---|---|---|---|
| BlackRock | 44,007,348 | $932,955,786 | — | 8/13/2024 |
| Vanguard Group | 64,904,889 | $743,810,028 | — | 1/29/2026 |
| State Street | 20,209,406 | $231,599,793 | — | 2/13/2026 |
| Fidelity (FMR) | 7,670,732 | $87,906,592 | — | 2/17/2026 |
| DE Shaw | 6,215,923 | $71,234,478 | — | 2/17/2026 |
| AQR Capital | 4,391,597 | $50,327,700 | — | 2/17/2026 |
| Millennium Management | 3,668,997 | $42,046,706 | — | 2/17/2026 |
| Citadel Advisors | 1,644,956 | $18,851,196 | — | 2/17/2026 |
| JP Morgan Chase | 1,192,645 | $13,667,712 | — | 2/11/2026 |
| Two Sigma | 412,713 | $4,729,691 | — | 2/17/2026 |